4.5 Review

Intracranial hemorrhage in patients treated for SARS-CoV-2 with extracorporeal membrane oxygenation: A systematic review and meta-analysis

Related references

Note: Only part of the references are listed.
Article Hematology

Impact of major bleeding and thrombosis on 180-day survival in patients with severe COVID-19 supported with veno-venous extracorporeal membrane oxygenation in the United Kingdom: a multicentre observational study

Deepa J. Arachchillage et al.

Summary: Bleeding and thrombosis are common complications in patients supported with ECMO, associated with increased mortality risk. Major bleeding and intracranial bleeding increase the risk of mortality by nearly 4-fold, while pulmonary embolism increases mortality risk by 2-fold.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Article Critical Care Medicine

Intracranial Hemorrhages on Extracorporeal Membrane Oxygenation: Differences Between COVID-19 and Other Viral Acute Respiratory Distress Syndrome

Benjamin Seeliger et al.

Summary: This multicenter retrospective analysis investigates the risk of intracranial hemorrhage in COVID-19 patients receiving ECMO support. The results show a higher incidence and severity of intracranial hemorrhage in COVID-19 patients compared to viral non-COVID-19 patients on ECMO, with a higher ICU mortality rate.

CRITICAL CARE MEDICINE (2022)

Article Cardiac & Cardiovascular Systems

Venovenous extracorporeal membrane oxygenation for patients with refractory coronavirus disease 2019 (COVID-19): Multicenter experience of referral hospitals in a large health care system

Emily Shih et al.

Summary: This study demonstrates the benefits of ECMO for patients with severe acute respiratory distress syndrome caused by COVID-19. In this study, 64.8% of patients survived after decannulation from ECMO, and 56.8% of patients survived to discharge.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2022)

Article Engineering, Biomedical

Observational study of thrombosis and bleeding in COVID-19 VV ECMO patients

Brianda Ripoll et al.

Summary: In patients with COVID-19 requiring veno-venous ECMO support, a high prevalence of VTE and a significant number of hemorrhages were observed. Extracorporeal oxygenation and whole body CT scans played a crucial role in diagnosing and managing thrombotic and bleeding events in these severely ill patients.

INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS (2022)

Article Medicine, General & Internal

Association of COVID-19 with Intracranial Hemorrhage during Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: A 10-Year Retrospective Observational Study

Tobias Pantel et al.

Summary: ICRH occurs more frequently in COVID-19 patients than in those with ARDS from other causes during vv-ECMO treatment. COVID-19 and carboxyhemoglobin are associated with ICRH during vv-ECMO.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Engineering, Biomedical

Improving Extracorporeal Membrane Oxygenation Survival in COVID-19. Effect of a Bundle of Care

Leonardo Salazar et al.

Summary: During the COVID-19 pandemic, changes were made to the model of care for Veno-venous extracorporeal membrane oxygenation (ECMO) patients in order to improve outcomes. By increasing the number of ECMO beds and training more healthcare professionals, and implementing early diagnostic and therapeutic interventions such as tracheostomy, fiberoptic bronchoscopy, and microbiological molecular diagnosis, the mortality rate of ECMO patients significantly decreased.

ASAIO JOURNAL (2022)

Article Anesthesiology

Venovenous Extracorporeal Membrane Oxygenation in Awake Non-Intubated Patients With COVID-19 ARDS at High Risk for Barotrauma

Gianluca Paternoster et al.

Summary: This study evaluates the efficacy of awake VV-ECMO strategy in preventing clinically relevant barotrauma in COVID-19 patients with severe ARDS. The results show that the awake VV-ECMO strategy can effectively prevent the development of PNX/PMD, but it also carries a risk of severe complications.

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2022)

Article Anesthesiology

Venovenous Extracorporeal Membrane Oxygenation in Awake Non-Intubated Patients With COVID-19 ARDS at High Risk for Barotrauma

Gianluca Paternoster et al.

Summary: This case series assessed the efficacy of awake VV-ECMO in preventing pneumothorax/pneumomediastinum in patients with COVID-19. The study found that awake VV-ECMO may be a feasible and safe strategy for preventing these complications in high-risk patients.

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2022)

Article Critical Care Medicine

316: EXTRACORPOREAL MEMBRANE OXYGENATION FOR COVID-19 ARDS TREATMENT IN A COMMUNITY HOSPITAL

Milica Antic et al.

CRITICAL CARE MEDICINE (2021)

Article Critical Care Medicine

304: INTRACRANIAL HEMORRHAGE DURING THE USE OF VENOVENOUS ECMO IN COVID 19: A CASE SERIES

AMREETA SHARMA et al.

CRITICAL CARE MEDICINE (2021)

Article Critical Care Medicine

Increased Intracranial Hemorrhage Amid Elevated Inflammatory Markers in Those With COVID-19 Supported With Extracorporeal Membrane Oxygenation

Rene S. Bermea et al.

Summary: The study evaluated the incidence and etiology of intracranial hemorrhage (ICH) in COVID-19 patients requiring ECMO support, with all ICH events occurring in patients who received intravenous anticoagulation. Patients with ICH had higher levels of inflammatory markers and lower blood pH, as well as higher activated partial thromboplastin times.ICH-free survival was lower in COVID-19 patients compared to those with other viral respiratory infections.

SHOCK (2021)

Article Engineering, Biomedical

Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization

Jenelle Badulak et al.

Summary: The guideline emphasizes the importance of ECMO treatment for COVID-19 patients, recommending the use of V-V ECMO for ARDS. More stringent contraindications should be implemented when resources are limited, and establishing regional ECMO referral networks can help expedite patient referrals.

ASAIO JOURNAL (2021)

Article Clinical Neurology

Microbleed patterns in critical illness and COVID-19

Jonas Toeback et al.

Summary: This study identified cerebral microbleeds in COVID-19 patients, with some cases exhibiting a typical pattern associated with critical illness, while others showed a new pattern of widespread cortical microbleeds. Further investigation is needed to determine the etiologies and associations with COVID-19.

CLINICAL NEUROLOGY AND NEUROSURGERY (2021)

Article Critical Care Medicine

Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19

Shahzad Shaefi et al.

Summary: Limited data on venovenous extracorporeal membrane oxygenation (ECMO) in patients with severe hypoxemic respiratory failure from COVID-19 were examined in a multicenter cohort study. Findings suggest that ECMO may reduce mortality in select patients with severe respiratory failure from COVID-19.

INTENSIVE CARE MEDICINE (2021)

Article Critical Care Medicine

Intracerebral Hemorrhage in COVID-19 Patients with Pulmonary Failure: A Propensity Score-Matched Registry Study

Corinna N. Lang et al.

Summary: In this study, it was found that patients with ARDS due to COVID-19 had a similar risk of intracerebral hemorrhage compared to other causes of ARDS. Despite the higher use of antiplatelet agents and therapeutic anticoagulation in COVID-19 patients, the rate of ICH was comparable between the two groups.

NEUROCRITICAL CARE (2021)

Article Critical Care Medicine

A Comparison of Thrombosis and Hemorrhage Rates in Patients With Severe Respiratory Failure Due to Coronavirus Disease 2019 and Influenza Requiring Extracorporeal Membrane Oxygenation

Andrew J. Doyle et al.

Summary: This study revealed that patients with coronavirus disease 2019 receiving extracorporeal membrane oxygenation had higher rates of venous thromboembolism and hemorrhage compared to patients with influenza.

CRITICAL CARE MEDICINE (2021)

Article Medicine, General & Internal

Extracorporeal Membrane Oxygenation for COVID 2019-Acute Respiratory Distress Syndrome: Comparison between First and Second Waves (Stage 2)

Nicolas Dognon et al.

Summary: The study aimed to compare outcomes of COVID-19 patients with Acute Respiratory Distress Syndrome treated with V-V ECMO during the first and second waves. While the 90-day mortality did not significantly differ between waves, more patients in the second wave received steroid treatment, had longer non-invasive ventilation support duration, and exhibited poorer lung mechanical properties. The second wave also saw more bacterial co-infections and less encouraging outcomes despite evidence-based critical care management.

JOURNAL OF CLINICAL MEDICINE (2021)

Letter Anesthesiology

Neurologic Injury in Patients With COVID-19 Who Receive VV-ECMO Therapy: A Cohort Study

Nivedha V. Kannapadi et al.

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2021)

Article Cardiac & Cardiovascular Systems

Thromboembolic and Bleeding Events in COVID-19 Patients receiving Extracorporeal Membrane Oxygenation

Koray Durak et al.

Summary: This study investigated the incidence of thromboembolic and bleeding events in COVID-19 patients treated with ECMO. The most common adverse event during ECMO support was bleeding, occurring at a rate comparable to non-COVID-19 patients. The platelet count was significantly lower in the bleeding event group compared to the non-bleeding event group.

THORACIC AND CARDIOVASCULAR SURGEON (2021)

Article Critical Care Medicine

Long Runs and. Higher Incidence of Bleeding Complications in COVID-19 Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: A Case Series from the United Arab Emirates

Vivek Kakar et al.

Summary: This case series reports on 12 COVID-19 related ARDS patients who received long ECMO treatment, with a majority being male and a 50% survival rate, but also experiencing higher rates of major bleeding complications.

INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2021)

Article Critical Care Medicine

Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study

Guillaume Lebreton et al.

Summary: This study analyzed adult patients admitted to intensive care units in Greater Paris for ECMO treatment during the early stages of the COVID-19 pandemic. Most patients were male and prone positioned before ECMO. The 90-day survival rate after ECMO treatment was 46%, with the main causes of death being multiorgan failure and septic shock.

LANCET RESPIRATORY MEDICINE (2021)

Article Engineering, Biomedical

Six Month Mortality in Patients with COVID-19 and Non-COVID-19 Viral Pneumonitis Managed with Veno-Venous Extracorporeal Membrane Oxygenation

Benjamin Garfield et al.

Summary: The study suggests that survival in patients supported with ECMO for COVID-19 is at least as good as those treated for non-COVID-19 viral ARDS.

ASAIO JOURNAL (2021)

Article Critical Care Medicine

Ischemic and Hemorrhagic Stroke Among Critically Ill Patients With Coronavirus Disease 2019: An International Multicenter Coronavirus Disease 2019 Critical Care Consortium Study*

Sung-Min Cho et al.

Summary: In an international cohort of ICU patients with coronavirus disease 2019, stroke was infrequent. Hemorrhagic stroke, but not ischemic stroke, was associated with increased mortality. Further, both hemorrhagic stroke and ischemic stroke were associated with traditional vascular risk factors.

CRITICAL CARE MEDICINE (2021)

Article Clinical Neurology

Neurological symptoms and complications in predominantly hospitalized COVID-19 patients: Results of the European multinational Lean European Open Survey on SARS-Infected Patients (LEOSS)

Nina N. Kleineberg et al.

Summary: This study analyzed real-world data from a multinational registry to evaluate the clinical relevance of neurological signs, symptoms, and complications in COVID-19 patients. The findings suggest that excessive tiredness and prior neurodegenerative diseases increase the risk of an unfavorable short-term outcome, while prior cerebrovascular and neuroimmunological diseases are not associated with an unfavorable outcome.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Article Surgery

Extracorporeal Membrane Oxygenation with Right Ventricular Assist Device for COVID-19 ARDS

Michael T. Cain et al.

Summary: In patients with COVID-19 ARDS, simultaneous RVAD/ECMO treatment was associated with lower mortality and a reduced incidence of acute kidney injury compared to IMV alone. However, there were no significant differences in ICU stay and duration of mechanical ventilation.

JOURNAL OF SURGICAL RESEARCH (2021)

Article Medicine, General & Internal

Hemorrhage and venous thromboembolism in critically ill patients with COVID-19

Chenyang Qiu et al.

Summary: COVID-19 patients and those with community-acquired pneumonia who required intensive care unit admission were at risk for venous thromboembolism and hemorrhage, with distal deep venous thrombosis being the most common type of thromboembolism. Hemorrhage was more common in COVID-19 patients and those receiving extracorporeal membrane oxygenation, but could be managed with blood transfusion and sometimes surgical/endoscopic treatments.

SAGE OPEN MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

SARS-CoV-2 and ECMO: early results and experience

Waqas Akhtar et al.

Summary: In this study, experiences and outcomes of severe SARS-CoV-2 patients requiring ECMO support at St Bartholomew's Hospital were retrospectively analyzed. Out of the 18 patients, 78% survived with 22% mortality, and 56% required renal replacement therapy. Thromboembolic events and renal injury were common in these patients.

INDIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2021)

Article Critical Care Medicine

Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations

Brijesh Patel et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Article Medicine, General & Internal

Clinical and Imaging Characteristics in Patients with SARS-CoV-2 Infection and Acute Intracranial Hemorrhage

Jawed Nawabi et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Article Anesthesiology

A Case Series of Devastating Intracranial Hemorrhage During Venovenous Extracorporeal Membrane Oxygenation for COVID-19

Asad Ali Usman et al.

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2020)

Editorial Material Clinical Neurology

Critical illness-associated cerebral microbleeds in COVID-19 acute respiratory distress syndrome

Octave Cannac et al.

NEUROLOGY (2020)

Article Clinical Neurology

Acute Cerebrovascular Events in Hospitalized COVID-19 Patients

Aaron Rothstein et al.

STROKE (2020)

Article Neurosciences

Hemorrhagic stroke in setting of severe COVID-19 infection requiring Extracorporeal Membrane Oxygenation (ECMO)

Muhammad J. Zahid et al.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2020)

Article Cardiac & Cardiovascular Systems

Intracranial hemorrhage in adults on ECMO

Yiorgos Alexandros Cavayas et al.

PERFUSION-UK (2018)

Review Medicine, General & Internal

Novel Surfaces in Extracorporeal Membrane Oxygenation Circuits

Andrea Ontaneda et al.

FRONTIERS IN MEDICINE (2018)

Article Critical Care Medicine

Predictors of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation: an observational cohort study

Alexander Fletcher Sandersjoo et al.

JOURNAL OF INTENSIVE CARE (2017)

Article Cardiac & Cardiovascular Systems

Trends in U.S. Extracorporeal Membrane Oxygenation Use and Outcomes: 2002-2012

Fenton H. McCarthy et al.

SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY (2015)